Outlook Therapeutics (OTLK) Change in Cash: 2015-2024
Historic Change in Cash for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to -$8.5 million.
- Outlook Therapeutics' Change in Cash fell 89.93% to -$11.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $4.5 million, marking a year-over-year decrease of 28.23%. This contributed to the annual value of -$8.5 million for FY2024, which is 241.19% down from last year.
- Latest data reveals that Outlook Therapeutics reported Change in Cash of -$8.5 million as of FY2024, which was down 241.19% from $6.0 million recorded in FY2023.
- Over the past 5 years, Outlook Therapeutics' Change in Cash peaked at $6.0 million during FY2023, and registered a low of -$8.5 million during FY2024.
- Its 3-year average for Change in Cash is $150,071, with a median of $2.9 million in 2022.
- Per our database at Business Quant, Outlook Therapeutics' Change in Cash surged by 105.35% in 2023 and then tumbled by 241.19% in 2024.
- Outlook Therapeutics' Change in Cash (Yearly) stood at $4.5 million in 2020, then plummeted by 57.05% to $1.9 million in 2021, then surged by 50.39% to $2.9 million in 2022, then spiked by 105.35% to $6.0 million in 2023, then slumped by 241.19% to -$8.5 million in 2024.